Effects of Probiotic and Synbiotic Supplementation on Metabolic and Hepatic Outcomes in Children and Adolescents With Obesity, Including Those With Obesity‐Related Metabolic Dysfunction–Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis
- 10 April 2026
- journal article
- review article
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 62 (5) , 678-696
Abstract
Aim: This systematic review and meta‐analysis evaluated the effects of probiotic and synbiotic supplementation on metabolic and hepatic outcomes in children and adolescents with obesity, including those with obesity‐related metabolic dysfunction–associated steatotic liver disease (MASLD). Methods: A comprehensive literature search of PubMed, Scopus and Web of Science was conducted up to September 2025. Randomised controlled trials (RCTs) investigating probiotic or synbiotic supplementation in paediatric populations with obesity or MASLD were included. Data were pooled using a random‐effects model, and the Cochrane Risk of Bias tool and GRADE framework were used for quality assessment. Results: Thirteen RCTs ( n = 848) were included. Pooled analyses demonstrated significant reductions in total cholesterol (WMD: −6.40 mg/dL, 95% CI: −8.78, −4.01), LDL‐C (WMD: −2.68 mg/dL, 95% CI: −4.85, −0.50) and alanine aminotransferase (ALT) (WMD: −6.15 U/L, 95% CI: −10.14, −2.16). No significant improvements were observed in BMI z ‐score, waist circumference, triglycerides, HDL‐C or fasting blood sugar. A significant increase in HOMA‐IR was found (WMD: 0.68, 95% CI: 0.53, 0.83). Evidence certainty was high for lipid outcomes but low or very low for most other measures. Conclusions: Despite these mixed results, substantial heterogeneity and limited evidence quality underscore the need for well‐designed, strain‐specific trials. Probiotic and synbiotic supplementation show promise for specific metabolic outcomes in paediatric populations, though caution is warranted regarding glucose homeostasis, and personalised approaches should be considered in clinical practice.Keywords
This publication has 49 references indexed in Scilit:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025Obesity Pillars, 2025
- Meta-analysis of the effects of probiotics on hyperlipidemiaCurrent Research in Food Science, 2024
- The synbiotic combination of probiotics and inulin improves NAFLD though modulating gut microbiotaThe Journal of Nutritional Biochemistry, 2023
- Effects of synbiotic supplementation on anthropometric indices and body composition in overweight or obese children and adolescents: a randomized, double-blind, placebo-controlled clinical trialWorld Journal of Pediatrics, 2022
- A randomized double-blind placebo controlled pilot study of probiotics in adolescents with severe obesityJournal of Diabetes & Metabolic Disorders, 2021
- Effects of probiotics on body adiposity and cardiovascular risk markers in individuals with overweight and obesity: A systematic review and meta-analysis of randomized controlled trialsClinical Nutrition, 2021
- Pediatric nonalcoholic fatty liver disease and the microbiome: Mechanisms contributing to pathogenesis and progressionCurrent Opinion in Endocrine and Metabolic Research, 2021
- Alanine Aminotransferase and Gamma‐Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic SteatohepatitisHepatology, 2020
- Effects of pro-/synbiotic supplementation on anthropometric and metabolic indices in overweight or obese children and adolescents: A systematic review and meta-analysisComplementary Therapies in Medicine, 2019
- Probiotics, prebiotics and synbiotics- a reviewJournal of Food Science and Technology, 2015